EIR CP Pharmaceuticals May 2001

Regina Brown FDA, Lydia Rosas Marty FDA$595.00 - Available Now

FDA investigators audited the CP Pharmaceuticals - Wrexham, United Kingdom facility and issued inspectional observation (via FDA 483) on 24 May 2001.

Product details

  • Category:
  • Inspection end: 24 May 2001
  • Location: Wrexham, United Kingdom
  • FEI: 3003369660
Add To Cart